Ezrin (EZR) promotes breast cancer progression and drug resistance: Molecular mechanisms involving STAT3 activation
Fields of Study & Subjects
Neuropeptides and Animal Physiology
Neurofibromatosis and Schwannoma Cases
Neuroendocrine Tumor Research Advances
Publication details
- Journal / source
- Life Sciences
- Publisher
- Elsevier BV
- Volume
- 390
- Pages
- 124250–124250
- Publication date
- 31 January 2026
- Language
- EN